BIONDI ANDREA

Acunzo, D., Bertagna, M., Risca, G., Beneforti, L., Bresolin, S., Galimberti, S., et al. (2026). Targeting oncogene-induced senescence in ETV6::RUNX1 pre-leukemic cells. CELL DEATH DISCOVERY, 12(1) [10.1038/s41420-026-03001-5]. Detail

Balduzzi, A., Valsecchi, M., Tran, T., Zuna, J., Leoni, V., Cario, G., et al. (2026). Philadelphia chromosome-positive acute lymphoblastic leukaemia in children and adolescents: A changing treatment landscape and a methodological challenge. BRITISH JOURNAL OF HAEMATOLOGY, 208(3), 1127-1132 [10.1111/bjh.70288]. Detail

Peccatori, N., Curto, A., Silvestri, D., Rebellato, S., Antic, Z., Bhatia, S., et al. (2026). PEDIATRIC PAX5-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IS A HIGH-RISK MOLECULAR SUBGROUP OF B-ALL WITH A POOR MRD-DEPENDENT PROGNOSTIC PROFILE. HAEMATOLOGICA, 111(1), 1-1 [10.3324/haematol.2026.s1.54]. Detail

Verna, M., Benitez, M., Canesi, M., Noguera, H., Conter, V., Rovelli, A., et al. (2026). Building a Pediatric Hematopoietic Stem Cell Transplantation Unit In Paraguay: Lessons Learned. TRANSPLANTATION AND CELLULAR THERAPY [10.1016/j.jtct.2026.01.016]. Detail

Colombo, D., Sala, A., Modola, M., L'Imperio, V., Rambaldi, A., Biondi, A., et al. (2026). Successful Treatment of Multirefractory Immune Thrombocytopenia in Rubinstein–Taybi Syndrome With Combined Rituximab and Eltrombopag. PEDIATRIC BLOOD & CANCER, 73(5 (May 2026)) [10.1002/1545-5017.70172]. Detail